Coloma Jason V

CIK 00016761703 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001676170

Recent Transactions

21 trades

Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-08-03$26.71/sh−30,304→ 256,867 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-08-03$27.09/sh−1,604→ 255,263 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-08-03$26.71/sh−2,439→ 20,898 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-08-03$27.09/sh−154→ 20,744 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-07-01$29.95/sh−30,311→ 288,768 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-07-01$30.44/sh−1,597→ 287,171 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-07-01$29.98/sh−2,593→ 23,337 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-06-23$26.05/sh−23,865→ 319,079 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-06-22$26.00/sh−1,953→ 342,944 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-06-22$26.00/sh−2,040→ 25,930 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-06-01$26.20/sh−6,090→ 344,897 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-06-01$26.24/sh−553→ 27,970 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-05-26$26.02/sh−25,582→ 350,987 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-05-22$26.00/sh−4,504→ 376,569 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-05-22$26.00/sh−2,478→ 28,523 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-05-15$26.00/sh−1,822→ 381,073 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-05-15$26.00/sh−116→ 31,001 total
Award
Maze Therapeutics, Inc.$MAZE
Restricted Stock Units
2026-03-02+75,000→ 75,000 total
Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-03-02+150,000→ 150,000 total
Award
Maze Therapeutics, Inc.$MAZE
Restricted Stock Units
2025-09-22+100,000→ 100,000 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2016-06-08+200,000→ 200,000 total

Companies

Recent Filings

Address

C/O BRAVEHEART BIO, INC. ONE LETTERMAN DR., BLDG. A, SUITE A4-300

SAN FRANCISCO, CA, 94129

View on SEC.gov